Silexion Therapeutics to Attend BIO International Convention 2026
(“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for …
(“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for …
Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
The collaboration brings clinical and behavioural weight management together, offering UK members a more integrated pat…
NeOnc Technologies Holdings (NASDAQ: NTHI) continues to build momentum as a neuro-oncology sector trailblazer For indus…
HCPro and ZHealth Publishing Partner to Advance Specialty Coding Excellence in Interventional Radiology and Cardiovascu…
Protein Industries Canada announces two projects focused on advancing Canada’s domestic food production capacity
UBC MOSAIC and LifeLabs Unlock New Ways to Manage and Predict Heart Health
King Faisal Specialist Hospital & Research Centre (KFSH) is building on its participation at HLTH Europe 2026, taking p…
Le KFSH met en avant une infrastructure d’innovation comme socle de la transformation évolutive des soins de santé au s…
Vibrant Ingredients renewed its partnership with Soldiers' Angels to support veterans and military families facing food…
, June 16, 2026 /PRNewswire/ -- This June as part of Men's Health Month, The Peanut Institute is sharing a variety of w…
Issued on behalf of Conexeu Sciences Inc.